Your competitors are
running trials 50% faster.
Here's how
Aika is the only explainable AI to accelerate your
clinical trials lifecycle.
Partners with
Your competitors are
running trials 50% faster.
Here's how
Aika is the only explainable AI that accelerates your clinical trials lifecycle. Starting today.
Partners with
Your competitors are running trials 50% faster.
Here's how.
Aika is the only explainable AI to accelerate your
clinical trials lifecycle.
Partners with
Smarter. Faster. Intuitive.
Meet Aika
The AI platform accelerating clinical trials
Aika is the first AI-native platform for clinical trials, unifying solutions for protocol design, feasibility, and regulatory planning in one intuitive workspace. It helps clinical teams accelerate trial setup, reduce risk, and bring treatments to patients faster.
AI-accelerated protocol creation, feasibility, and alignment.
Accelerated design
AI-accelerated protocol creation, feasibility, and alignment.
Accelerated design
AI-accelerated protocol creation, feasibility, and alignment.
Accelerated design
AI-accelerated protocol creation, feasibility, and alignment.
Amendment prevention
AI-accelerated protocol creation, feasibility, and alignment.
Amendment prevention
AI-accelerated protocol creation, feasibility, and alignment.
Amendment prevention
AI-accelerated protocol creation, feasibility, and alignment.
100% explainable decisions
AI-accelerated protocol creation, feasibility, and alignment.
100% explainable decisions
AI-accelerated protocol creation, feasibility, and alignment.
100% explainable decisions
AI-accelerated protocol creation, feasibility, and alignment.
Based on
~1 million real trials
AI-accelerated protocol creation, feasibility, and alignment.
Based on
~1 million real trials
AI-accelerated protocol creation, feasibility, and alignment.
Based on
~1 million real trials
What could you save
Nobody can explain how it works.
Calculate your potential savings based on real data from our clinical trial platform.
Calculate your potential savings based on real data from our clinical trial platform.
The problem with AI in clinical trials?
The problem with AI in clinical trials?
Nobody can explain how it works.
Nobody can explain how it works.
Download the Aika Transparency Report
Download the Aika Transparency Report
No email required
No email required
Testimonials
Trusted by Leaders. Backed by Science.
Based on ~1 million real trials.
“Biorce is exactly the kind of pioneering company we’re here to back. They’re combining deep sector expertise with cutting-edge AI to solve what truly matters. Their platform has the potential to radically reduce both the time and cost of bringing new treatments to market, unlocking huge value for pharma and, more importantly, faster access to life-saving therapies for patients.”
Tove Larsson
General Partner | Norrsken VC
Used across US, EU & APAC by global clinical trial teams.
"The expansive potential of Jarvis hints at a wealth of untapped applications beyond drugs development; it opens the door to evolutionary possibilities that could help redefine efficiency and precision in the broader medical field"
Ricardo Matias
CRIO | Co-Founder of Kinetikos
Built by former CRO, clinicians, regulatory, and AI leaders.
$5M invested by Norrsken, Europe’s leading impact VC to reinvent clinical trials.
"I think this is a fantastic tool for clinical trialists that will not only save time but could potentially reduce the number of avoidable protocol amendments, saving costs and enhancing confidence in evaluation of the study objectives"
Laurence Skillern
Medical Director | CMO of ISTESSO
Trusted by Leaders. Backed by Science.
Based on ~1 million real trials.
“Biorce is exactly the kind of pioneering company we’re here to back. They’re combining deep sector expertise with cutting-edge AI to solve what truly matters. Their platform has the potential to radically reduce both the time and cost of bringing new treatments to market, unlocking huge value for pharma and, more importantly, faster access to life-saving therapies for patients.”
Tove Larsson
General Partner | Norrsken VC
Used across US, EU & APAC by global clinical trial teams.
"The expansive potential of Jarvis hints at a wealth of untapped applications beyond drugs development; it opens the door to evolutionary possibilities that could help redefine efficiency and precision in the broader medical field"
Ricardo Matias
CRIO | Co-Founder of Kinetikos
Built by former CRO, clinicians, regulatory, and AI leaders.
$5M invested by Norrsken, Europe’s leading impact VC to reinvent clinical trials.
"I think this is a fantastic tool for clinical trialists that will not only save time but could potentially reduce the number of avoidable protocol amendments, saving costs and enhancing confidence in evaluation of the study objectives"
Laurence Skillern
Medical Director | CMO of ISTESSO